ZA200806986B - Treatment of duchenne muscular dystrophy - Google Patents

Treatment of duchenne muscular dystrophy

Info

Publication number
ZA200806986B
ZA200806986B ZA200806986A ZA200806986A ZA200806986B ZA 200806986 B ZA200806986 B ZA 200806986B ZA 200806986 A ZA200806986 A ZA 200806986A ZA 200806986 A ZA200806986 A ZA 200806986A ZA 200806986 B ZA200806986 B ZA 200806986B
Authority
ZA
South Africa
Prior art keywords
treatment
muscular dystrophy
duchenne muscular
duchenne
dystrophy
Prior art date
Application number
ZA200806986A
Inventor
Graham Michael Wynne
Stephen Paul Wren
Peter David Johnson
Paul Damien Price
Moor Olivier De
Gary Nugent
Richard Storer
Richard Joseph Pye
Colin Richard Dorgan
Original Assignee
Summit Corp Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp Plc filed Critical Summit Corp Plc
Publication of ZA200806986B publication Critical patent/ZA200806986B/en

Links

ZA200806986A 2006-02-10 2007-02-09 Treatment of duchenne muscular dystrophy ZA200806986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0602768A GB0602768D0 (en) 2006-02-10 2006-02-10 Treatment of muscular dystrophy

Publications (1)

Publication Number Publication Date
ZA200806986B true ZA200806986B (en) 2010-02-24

Family

ID=36119905

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806986A ZA200806986B (en) 2006-02-10 2007-02-09 Treatment of duchenne muscular dystrophy

Country Status (3)

Country Link
CN (1) CN101420950B (en)
GB (1) GB0602768D0 (en)
ZA (1) ZA200806986B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012006630A2 (en) * 2009-09-24 2016-05-03 Hoffmann La Roche indole derivatives as calcium channel activated calcium channel modulators (crac)
US9453012B2 (en) * 2012-03-06 2016-09-27 Compound Handling B.V. Aminomethylene pyrazolones with therapeutic activity
WO2016021706A1 (en) * 2014-08-08 2016-02-11 カズマパートナーズ株式会社 Condensed heterocyclic compound
EP3085785A1 (en) * 2015-04-22 2016-10-26 Université de Strasbourg Dynamin 2 inhibitor for the treatment of duchenne's muscular dystrophy
JP2019510056A (en) * 2016-03-30 2019-04-11 サミット （オックスフォード） リミテッド Composition for the treatment of Duchenne muscular dystrophy
CN113195084B (en) * 2018-10-10 2024-04-09 阿尔伯爱因斯坦医学院 Benzoxazoles and related compounds useful as modulators of chaperone mediated autophagy
CN110981827A (en) * 2019-11-29 2020-04-10 浙江工业大学 Synthesis method of 4- (5-nitrobenzo [ d ] oxazole-2-yl) aniline
CN113264894A (en) * 2021-05-24 2021-08-17 陕西维世诺新材料有限公司 Benzoxazole derivative and preparation method thereof
CN113372293A (en) * 2021-06-25 2021-09-10 陕西维世诺新材料有限公司 Preparation method of 2-phenylbenzothiazole derivative
CN118126036A (en) * 2022-12-01 2024-06-04 复旦大学 7-Azaindole compound and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815880D0 (en) * 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
GB0003256D0 (en) * 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
WO2004041277A1 (en) * 2002-11-01 2004-05-21 Merck & Co., Inc. Carbonylamino-benzimidazole derivatives as androgen receptor modulators

Also Published As

Publication number Publication date
CN101420950A (en) 2009-04-29
GB0602768D0 (en) 2006-03-22
CN101420950B (en) 2012-04-18

Similar Documents

Publication Publication Date Title
IL228598A0 (en) Treatment of duchenne muscular dystrophy
IL193314A0 (en) Treatment of duchenne muscular dystrophy
GB0715938D0 (en) Method of treatment of duchenne muscular dystrophy
PT2170396T (en) Drug combinations for the treatment of duchenne muscular dystrophy
GB0715087D0 (en) Drug combinations for the treatment of duchenne muscular dystrophy
GB0815369D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0821307D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0822981D0 (en) Compounds for treatment of duchenne muscular dystrophy
IL193183A0 (en) Method of treatment for muscular dystrophy
ZA200806986B (en) Treatment of duchenne muscular dystrophy
GB0715939D0 (en) Method of treatment of duchenne muscular dystrophy
GB0715937D0 (en) Method of treatment og duchenne muscular dystrophy
ZA201000225B (en) Treatment of depression
GB0905664D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0723100D0 (en) Treatment of HFnEF
GB0602767D0 (en) Treatment of muscular dystrophy
GB0809314D0 (en) Compounds for treating muscular dystrophy
GB0905670D0 (en) Compounds for treatment of duchenne muscular dystrophy
GB0617739D0 (en) Treatment of duchenne muscular dystrophy
GB0619282D0 (en) Treatment of duchenne muscular dystrophy
GB0619283D0 (en) Treatment of duchenne muscular dystrophy
GB0623985D0 (en) Treatment of duchenne muscular dystrophy
GB0623984D0 (en) Treatment of duchenne muscular dystrophy
GB0617737D0 (en) Treatment of duchenne muscular dystrophy
GB0617740D0 (en) Treatment of duchenne muscular dystrophy